Skip to main content

Amgen · Healthcare & Pharma

In AI answers about pharma, Amgen appears mostly as a supporting name in lists, not a storyline

Across benchmark questions that never named a brand, Amgen turned up in lists about assistance programs, executive pay and kickback settlements. Its press footprint is far larger than its footprint in these answers.

Measured September 29, 2026ChatGPT, Claude, Gemini, Perplexity and GrokCheck your own brand →

In AI answers

Visibility

6%

Share of answers that named Amgen, with a 95% range of 4–7%. Measured September 29, 2026 · 5 assistants · 1,250 answers.

Answers naming it

69 / 1,250

Position by visibility

#12 of 15

In this snapshot only

In the press

News mentions

20,317

PeakMetrics news index, last 30 days.

Amgen in the headline

1,660

Rank by press volume

#2 of 15

Within this sector

Amgen gets more press than AI mentions. It ranks #2 of 15 in this sector by news volume but #12 by how often the sampled AI answers named it. In this snapshot, coverage volume and AI visibility do not line up.

Named in 37 of 250 questions, the 12 most-named shown

Question
Which pharma companies do patient advocacy groups speak most highly of?Named by: ChatGPT, Claude, Gemini, Perplexity, Grok
Who are the most innovative drug makers working on obesity and weight loss treatments right now?Named by: Claude, Gemini, Perplexity, Grok
Which big drugmakers have been most criticized for raising prices on older medications?Named by: ChatGPT, Claude, Perplexity, Grok
Which biotech companies are considered industry leaders right now?Named by: ChatGPT, Claude, Perplexity, Grok
As an investor, which pharma companies have the most promising late-stage pipelines based on clinical results?Named by: ChatGPT, Gemini, Grok
Which companies that run clinical trials are the most transparent and ethical about publishing results?Named by: Claude, Perplexity, Grok
Which big pharma companies have been fined for bribing doctors or illegal kickbacks?Named by: Gemini, Perplexity, Grok
Rank the best biotech companies to work for right now.Named by: Claude, Gemini
Which pharma companies have pledged net-zero emissions, and which of them are actually on track?Named by: ChatGPT, Perplexity
Which drug companies have raised list prices the most over the past five years?Named by: Claude, Perplexity
I'm thinking about investing in healthcare stocks for the long term. Which companies are the financially strongest in the sector?Named by: Perplexity, Grok
Who are the biggest pharmaceutical companies in the world right now?Named by: Gemini, Grok

and 25 more questions whose answers named Amgen.

The evidence

One snapshot, measured September 29, 2026. These figures come from one quarterly run of 1,250 answers (95% range 4–7%), not a ranking or a trend. The questions never named Amgen.

How the answers frame Amgen

In this snapshot (measured 2026-09-29, five assistants, 250 benchmark questions each, 1,250 answers), Amgen was named in 69 answers. Grok accounted for the most, 26 of 250. ChatGPT and Perplexity each named it in 11, Claude in 12 and Gemini in 9. The data's credited-for field holds only "Not Substantive (3)", so the answers gave little that pins Amgen to a single strength.

In the four stored answers, Amgen is one name among many. Claude's answer on free drug programs for uninsured cancer patients gave it a specific line: "The Amgen Safety-Net Foundation offers financial assistance programs to under- and uninsured patients" for certain Amgen medications. ChatGPT's answer on executive pay and sustainability listed Amgen alongside Teva and Bristol Myers Squibb as an example of a drugmaker tying pay to such goals.

Amgen was also named in the answers to two questions with a critical edge. ChatGPT's answer on older-drug price hikes and Gemini's answer on kickback fines both listed it among the brands named. In the visible text of those two answers, the detail went to other companies: AbbVie and Valeant in one, GSK, Purdue, Pfizer and J&J in the other. The text supplied does not show what either answer said about Amgen.

By question intent, visibility was highest on leadership (13%) and sustainability (12%). It was 0% on value, service and safety, and 1% on reliability.

The Amgen Safety-Net Foundation offers financial assistance programs to under- and uninsured patients who've been prescribed certain Amgen medications…
Claude, answering “What companies make free drug programs for uninsured cancer patients?”

What the press is saying

PeakMetrics' news index shows 20,317 mentions of Amgen over the last 30 days. Only 1,660 carry the brand in the headline, so most coverage mentions it in passing.

The recent headlines split across three threads. One is sport: the Amgen Irish Open, covered for its weather forecast and for players' frustration over pace of play. Another is investing, with a Nasdaq comparison against Revolution Medicines and a Kalkine Media piece asking why the market is watching AMGN. The third is a company announcement of positive topline Phase 3 results for dazodalibep in Sjögren's disease.

The gap

Amgen's news volume sits near Pfizer (19,027), Eli Lilly (19,681) and Merck (20,731). Its answer footprint is much smaller: 69 appearances against 174 for Pfizer, 155 for Eli Lilly and 158 for Merck. Only Gilead Sciences and Moderna were named less often among the 15 companies in the peer set.

The press story mixes golf sponsorship, stock commentary and clinical news. The AI story, in the answers sampled, is about patient assistance, pay design and industry-wide controversy lists. Neither the Irish Open nor the Phase 3 result appears in the stored answers. Heavy coverage did not translate into a distinct role for Amgen in these answers.

What to watch

For a comms team, the concrete item is the Safety-Net Foundation line in Claude's answer, one of the few places where an assistant described what Amgen does. Check whether patient-access and sustainability-linked pay show up as recurring associations in wider runs.

Also read the full text of the answers where Amgen sits inside price and kickback lists, since the stored excerpts do not show how it is described there. This is one snapshot, and live answers vary between runs, so treat these figures as a baseline to re-measure and not as a ranking.

The evidence

Where Amgen appeared, and what it was credited for.

Per-provider split

The same answers split by assistant, each with its 95% range. Where two assistants' ranges overlap, the difference between them may be noise.

  1. ChatGPT
    4%3–8%
  2. Claude
    5%3–8%
  3. Gemini
    4%2–7%
  4. Perplexity
    4%3–8%
  5. Grok
    10%7–15%

Appeared in

The 12 questions whose answers named Amgen most often, with each assistant that named it. 37 questions named it in all. The questions did not mention the brand.

  • Which pharma companies do patient advocacy groups speak most highly of?ChatGPTClaudeGeminiPerplexityGrok
  • Who are the most innovative drug makers working on obesity and weight loss treatments right now?ClaudeGeminiPerplexityGrok
  • Which big drugmakers have been most criticized for raising prices on older medications?ChatGPTClaudePerplexityGrok
  • Which biotech companies are considered industry leaders right now?ChatGPTClaudePerplexityGrok
  • As an investor, which pharma companies have the most promising late-stage pipelines based on clinical results?ChatGPTGeminiGrok
  • Which companies that run clinical trials are the most transparent and ethical about publishing results?ClaudePerplexityGrok
  • Which big pharma companies have been fined for bribing doctors or illegal kickbacks?GeminiPerplexityGrok
  • Rank the best biotech companies to work for right now.ClaudeGemini
  • Which pharma companies have pledged net-zero emissions, and which of them are actually on track?ChatGPTPerplexity
  • Which drug companies have raised list prices the most over the past five years?ClaudePerplexity
  • I'm thinking about investing in healthcare stocks for the long term. Which companies are the financially strongest in the sector?PerplexityGrok
  • Who are the biggest pharmaceutical companies in the world right now?GeminiGrok

Visibility by question type

The share of answers to each type of question that named Amgen, with its 95% range. Each type has fewer answers than the whole run, so its range is wider.

  1. Reliability and quality
    1%0–5%
  2. Trust and reputation
    8%4–15%
  3. Value and price
    0%0–4%
  4. Customer service
    0%0–4%
  5. Safety and security
    0%0–4%
  6. Innovation
    7%4–14%
  7. Leadership and scale
    13%7–21%
  8. Employer and workplace
    7%4–14%
  9. Sustainability and ethics
    12%7–20%
  10. Avoid and risk
    7%3–15%
  11. Coverage and access to care
    4%2–10%
  12. Clinical outcomes and efficacy
    5%2–12%
  13. Pricing practices and transparency
    8%4–15%
Measured September 29, 2026. ChatGPT, Claude, Gemini, Perplexity and Grok. Types with no answers are left out.

What the answers credited it for

The topics the answers tied to Amgen when they named it, as labeled by a classifier run on this site (a Visibility Driver label, not a customer workspace's Smart Category). It describes what the answer discussed, not whether it was favorable.

  • Not Substantive3 answers

Press rank and AI rank

Where Amgen sits among the 15 healthcare & pharma brands with news data in this snapshot, on each measure. Ranks only: the two measures use different units and time windows.

Rank by AI visibility

#12 of 15

  1. 12

Share of 1,250 answers, measured September 29, 2026.

Rank by news mentions

#2 of 15

  1. 2

PeakMetrics news index, last 30 days.

Mention volume is not comparable across sectors, so both ranks are within this sector.

Recent PeakMetrics headlines

A sample of recent coverage from the PeakMetrics news index, covering the last 30 days. Links open the original article.

How this was measured

Measured September 29, 2026. 250 unbranded questions per sector, asked to ChatGPT, Claude, Gemini, Perplexity and Grok on their product models, with web search on. Refreshed quarterly.

This is a snapshot, not a ranking or a trend: AI answers vary from run to run. It shows whether a brand appeared and which sources were cited, not how favorably it was described. The paid platform tracks favorability daily.

Full method

In an early five-question test, the same brand went from 40% to 30% to 70% visibility across three runs, which is why every figure here is dated and treated as a snapshot.

The questions cover 13 intents, such as reliability, value for money and customer service. A model drafted them, a review pass removed paraphrases and questions that point to one company, and every question was checked so that none names a measured brand. Each was asked once per assistant in run 2026Q4.

Every visibility figure comes with a 95% range (a Wilson interval). Where two brands' ranges overlap, treat them as tied. The figures use all 1,250 answers. The quotes in the story come from a stratified sample of 60 of them, spread across every assistant and intent.

Summarized on September 30, 2026from this snapshot's stored answers. Every quote is checked against the original answer.

← Healthcare & Pharma sector reportCheck your own brand →

Related

Your brand

Run the same unbranded questions for your own category.

Check your own brand

Track how AI answers describe your brand every day.

AI Perceptions follows all 5 providers daily, next to the news and social coverage PeakMetrics already monitors.

Book a Demo